Latest Insights on FL
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Coronavirus Alert — Grab Double-Digit Gains When Stocks Rebound February 3, 2020 American Investor Today, Natural Resources
The coronavirus is spreading faster than the SARS outbreak in 2003. Markets are falling on fear of a global slowdown. But quick action from world leaders is helping contain the virus. Matt Badiali shares a contrarian strategy for buying great stocks at discounted prices.
No Fear Here: 4 Stocks to Beat the Wuhan Virus January 31, 2020 2020 Financial Crisis, Great Stuff
Friday Four Play: The “Fear Inoculum” Edition (Did a friend forward you this email? If so, you owe them big-time! Seriously, this is Great Stuff. We don’t take that title lightly. After you’ve thanked your friend profusely, why not sign up for yourself today? It’s mostly painless. I promise.) The Wuhan coronavirus is officially a […]
Tesla’s Cash Flows; Verizon’s Crossroads; Facebook Erodes January 30, 2020 Great Stuff
Tesla to Bears: Eat My Shorts Do we have any Tesla Inc. (Nasdaq: TSLA) bears reading today? I know you’re out there. You write in to Great Stuff every time I say something positive about the company. Well, get your emails ready. Today, Tesla’s taking a victory lap … and I’m saying: “I told you […]
You Gained 26% in 2 Days — Here’s What’s Next January 30, 2020 Global Economy, Investment Opportunities, Winning Investor Daily
If you took advantage of this trade, congratulations! You hedged yourself against larger losses when the market fell. But we’re not out of the woods yet.MEET OUR EXPERTS
Editor of Strategic Fortunes and three elite services
Research Analyst
Director of VIP Services
Chief Investment Strategist of Money & Markets
Editor of Alpha Investor
